森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/07/13 | 1,905 | 1,915 | 1,905 | 1,915 | +10 | +0.5% | 300 |
| 2022/07/12 | 1,900 | 1,905 | 1,891 | 1,905 | -4 | -0.2% | 1,100 |
| 2022/07/11 | 1,908 | 1,909 | 1,908 | 1,909 | +9 | +0.5% | 300 |
| 2022/07/08 | 1,892 | 1,900 | 1,892 | 1,900 | +5 | +0.3% | 500 |
| 2022/07/07 | 1,900 | 1,901 | 1,895 | 1,895 | -6 | -0.3% | 2,000 |
| 2022/07/06 | 1,905 | 1,905 | 1,901 | 1,901 | -5 | -0.3% | 600 |
| 2022/07/05 | 1,917 | 1,917 | 1,906 | 1,906 | -21 | -1.1% | 500 |
| 2022/07/04 | 1,929 | 1,929 | 1,926 | 1,927 | -2 | -0.1% | 400 |
| 2022/07/01 | 1,929 | 1,930 | 1,916 | 1,929 | ±0 | ±0% | 2,600 |
| 2022/06/30 | 1,923 | 1,931 | 1,920 | 1,929 | +10 | +0.5% | 1,600 |
| 2022/06/29 | 1,919 | 1,919 | 1,917 | 1,919 | ±0 | ±0% | 1,000 |
| 2022/06/28 | 1,948 | 1,948 | 1,908 | 1,919 | +20 | +1.1% | 3,400 |
| 2022/06/27 | 1,910 | 1,915 | 1,898 | 1,899 | - | - | 5,200 |
| 2022/06/24 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/06/23 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/06/22 | 1,880 | 1,885 | 1,870 | 1,883 | +14 | +0.7% | 1,200 |
| 2022/06/21 | 1,871 | 1,877 | 1,865 | 1,869 | -7 | -0.4% | 1,100 |
| 2022/06/20 | 1,873 | 1,876 | 1,870 | 1,876 | +3 | +0.2% | 500 |
| 2022/06/17 | 1,865 | 1,876 | 1,863 | 1,873 | +8 | +0.4% | 1,800 |
| 2022/06/16 | 1,865 | 1,865 | 1,865 | 1,865 | ±0 | ±0% | 500 |
| 2022/06/15 | 1,871 | 1,871 | 1,865 | 1,865 | -7 | -0.4% | 700 |
| 2022/06/14 | 1,873 | 1,874 | 1,865 | 1,872 | +3 | +0.2% | 1,400 |
| 2022/06/13 | 1,871 | 1,876 | 1,869 | 1,869 | -2 | -0.1% | 1,500 |
| 2022/06/10 | 1,881 | 1,881 | 1,871 | 1,871 | -10 | -0.5% | 1,000 |
| 2022/06/09 | 1,876 | 1,881 | 1,876 | 1,881 | +2 | +0.1% | 400 |
| 2022/06/08 | 1,870 | 1,879 | 1,868 | 1,879 | +9 | +0.5% | 1,100 |
| 2022/06/07 | 1,865 | 1,871 | 1,865 | 1,870 | +5 | +0.3% | 500 |
| 2022/06/06 | 1,872 | 1,872 | 1,865 | 1,865 | -7 | -0.4% | 1,700 |
| 2022/06/03 | 1,869 | 1,872 | 1,869 | 1,872 | +2 | +0.1% | 1,000 |
| 2022/06/02 | 1,884 | 1,884 | 1,870 | 1,870 | -14 | -0.7% | 2,900 |
| 2022/06/01 | 1,887 | 1,888 | 1,884 | 1,884 | -4 | -0.2% | 1,000 |
| 2022/05/31 | 1,875 | 1,888 | 1,875 | 1,888 | +10 | +0.5% | 2,200 |
| 2022/05/30 | 1,879 | 1,888 | 1,878 | 1,878 | -10 | -0.5% | 800 |
| 2022/05/27 | 1,886 | 1,888 | 1,876 | 1,888 | ±0 | ±0% | 1,300 |
| 2022/05/26 | 1,875 | 1,891 | 1,875 | 1,888 | +12 | +0.6% | 800 |
| 2022/05/25 | 1,898 | 1,898 | 1,876 | 1,876 | -18 | -1% | 1,300 |
| 2022/05/24 | 1,881 | 1,894 | 1,881 | 1,894 | -5 | -0.3% | 400 |
| 2022/05/23 | 1,876 | 1,899 | 1,876 | 1,899 | +21 | +1.1% | 1,300 |
| 2022/05/20 | 1,875 | 1,880 | 1,875 | 1,878 | -5 | -0.3% | 1,500 |
| 2022/05/19 | 1,878 | 1,894 | 1,878 | 1,883 | +5 | +0.3% | 900 |
| 2022/05/18 | 1,879 | 1,890 | 1,877 | 1,878 | -7 | -0.4% | 700 |
| 2022/05/17 | 1,877 | 1,891 | 1,877 | 1,885 | -8 | -0.4% | 600 |
| 2022/05/16 | 1,885 | 1,893 | 1,877 | 1,893 | +8 | +0.4% | 1,000 |
| 2022/05/13 | 1,884 | 1,885 | 1,877 | 1,885 | -9 | -0.5% | 400 |
| 2022/05/12 | 1,885 | 1,898 | 1,877 | 1,894 | +9 | +0.5% | 700 |
| 2022/05/11 | 1,876 | 1,897 | 1,876 | 1,885 | +9 | +0.5% | 700 |
| 2022/05/10 | 1,900 | 1,900 | 1,876 | 1,876 | -24 | -1.3% | 1,200 |
| 2022/05/09 | 1,876 | 1,917 | 1,876 | 1,900 | +24 | +1.3% | 4,200 |
| 2022/05/06 | 1,865 | 1,876 | 1,863 | 1,876 | -2 | -0.1% | 1,700 |
| 2022/05/02 | 1,870 | 1,878 | 1,867 | 1,878 | +7 | +0.4% | 1,300 |
751～
800
件表示中 / 3756件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 220,000円 | +0.3% | +9.2% | 2.95% | 12.52倍 | 0.74倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| カイオム | 14,200円 | +92.3% | - | 0.00% | - | 5.06倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| 坪田ラボ | 37,600円 | +3.2% | -21.7% | 0.00% | 64.27倍 | 6.08倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
| ＯＴＳ | 2,900円 | +33.3% | - | 0.00% | - | 13.43倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ケイファーマ | 72,500円 | - | - | 0.00% | - | 3.73倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム
